Whoop just announced a $575 million raise at a $10.1 billion valuation.
Cristiano Ronaldo is in the round. So is LeBron James, Rory McIlroy and Virgil van Dijk.
We all know that celebrity investors are essentially brand ambassadors with equity. So let's talk about what actually matters here, which is what this raise means for the $239 sitting on your wrist every year.
The numbers
Whoop exited 2025 at a $1.1 billion revenue run rate. 2.5 million members. Bookings up 103% year on year. Cash flow positive. Series G led by Collaborative Fund with Qatar Investment Authority, Mubadala, Abbott, Mayo Clinic and Macquarie Capital all in the round alongside the famous faces.
Those last five names are the ones worth pausing on. QIA and Mubadala are sovereign wealth funds managing hundreds of billions on behalf of entire nations. Macquarie finances airports and toll roads. Abbott is one of the largest medical device companies in the world. Mayo Clinic is arguably the most respected healthcare institution in America. These institutions do not write cheques for fitness gadgets. They buy into infrastructure they expect to matter in twenty years.
When capital like that backs your recovery tracker, it stops being a recovery tracker.
The part that affects you.
Whoop is valued at 9.2 times its current revenue. That is an aggressive multiple for a consumer subscription business and it comes with an expectation attached. Whoever just wrote those cheques needs a return, and a $10 billion valuation has to grow into itself before an IPO becomes viable. Bloomberg reported today that an IPO is exactly where this is heading.
So how does a subscription business justify a $10 billion public market valuation? There are only two levers. More subscribers or higher prices. Probably both.
Whoop has 2.5 million members today. To make the numbers work at current pricing they need to be closer to 4 or 5 million before they go public. They are less than halfway there. Subscriber growth alone will not close that gap fast enough.
So you look at the other lever. A move from $239 to $299 is a 25% price increase. On 2.5 million members that is an extra $150 million in annual revenue. For a board now answering to sovereign wealth funds, that is not a hard conversation to have.
Here is the uncomfortable truth about subscription products and big capital events.
Right now every single incentive Whoop has is pointed at keeping you happy. Your renewal rate is the product. Your habit of opening the app eight times a day is what made this raise possible. They needed you locked in and loyal before they could walk into a room and justify a $10 billion number.
The moment they file for an IPO that changes. Their primary audience becomes Wall Street, not you. Pricing decisions get pressure tested against shareholder return models. Product decisions get filtered through a prospectus. Your experience as a subscriber becomes a line item.
This is not speculation. Peloton, Strava, MyFitnessPal. Every major subscription fitness product that went through a significant capital event got more expensive and more complicated on the other side of it. The incentive structure shifted and the product followed.
However, Whoop does not operate in a empty market. Apple Watch, Oura and Garmin all exist. You cannot aggressively reprice into a market where credible alternatives sit at similar price points without losing members. Competition is the ceiling here and it is a real one.
The scale argument also has merit. More members means lower hardware costs and lower infrastructure costs per user. It is possible that $239 holds for longer than the pessimistic read suggests.
Here’s our opinion:
You handed Whoop your sleep data, your recovery scores, your heart rate variability trends and your annual renewal. That data, multiplied across 2.5 million members and 24 billion hours of physiological tracking, is a significant part of what just got valued at $10 billion.
Ronaldo and LeBron are in the deck because they make the press release travel. The sovereign wealth funds and the healthcare institutions are in the round because they see something much bigger than a fitness band. They see a personal health data platform with institutional scale, and they are betting that the people wearing it will keep paying for it regardless of what it costs.
Whether that includes you is a question worth asking now, before the IPO makes it harder to walk away.
In future issues, we are running a full cost breakdown on the Whoop 5.0 membership to tell you whether the $239 is actually worth it in the first place.